We are live on
!
Find out more
FRM
Fox Run Management Portfolio holdings
AUM
$572M
1-Year Est. Return
24.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.63%
1 Year Est. Return
+24.16%
3 Year Est. Return
+44.85%
5 Year Est. Return
+32.84%
10 Year Est. Return
+244.98%
AUM
$289M
AUM Growth
+$44.1M
(+18%)
Cap. Flow
+$42.9M
Cap. Flow
% of AUM
14.81%
Top 10 Holdings %
Top 10 Hldgs %
5.2%
Holding
950
New
406
Increased
107
Reduced
92
Closed
345
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Azenta
AZTA
|
+$1.66M |
| 2 |
ConocoPhillips
COP
|
+$1.5M |
| 3 |
United Airlines
UAL
|
+$1.46M |
| 4 |
MSCI
MSCI
|
+$1.46M |
| 5 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.39M |
| 2 |
Comcast
CMCSA
|
+$1.29M |
| 3 |
Walt Disney
DIS
|
+$1.27M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.24M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.46% |
| 2 | Consumer Discretionary | 13.76% |
| 3 | Technology | 13.34% |
| 4 | Industrials | 12.71% |
| 5 | Healthcare | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Keysight
KEYS
$55.6B
| $409K | 0.14% |
10,500
-5,074
| -33% | -$192K |
|
302
Zumiez
ZUMZ
$317M
| $408K | 0.14% |
+33,000
| New | +$504K |
|
303
NVIDIA
NVDA
$5.06T
| $405K | 0.14% |
+112,000
| New | +$356K |
|
304
Zoetis
ZTS
$31.3B
| $405K | 0.14% |
6,500
-5,100
| -44% | -$301K |
|
|
DRE
305
DELISTED
Duke Realty Corp.
DRE
| $405K | 0.14% |
+14,500
| New | +$407K |
|
|
SIOX
306
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $404K | 0.14% |
+2,175
| New | +$381K |
|
|
LPT
307
DELISTED
Liberty Property Trust
LPT
| $403K | 0.14% |
+9,900
| New | +$407K |
|
|
ALDR
308
DELISTED
Alder Biopharmaceuticals
ALDR
| $402K | 0.14% |
+35,100
| New | +$649K |
|
309
Martin Marietta Materials
MLM
$32.8B
| $401K | 0.14% |
+1,800
| New | +$407K |
|
310
AGNC Investment
AGNC
$12.3B
| $400K | 0.14% |
+18,800
| New | +$391K |
|
|
XYZ
311
Block Inc
XYZ
$45.5B
| $399K | 0.14% |
+17,000
| New | +$351K |
|
|
MPT
312
Medical Properties Trust
MPT
$2.87B
| $398K | 0.14% |
+30,900
| New | +$411K |
|
313
CubeSmart
CUBE
$9.29B
| $397K | 0.14% |
+16,500
| New | +$418K |
|
|
HMHC
314
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $397K | 0.14% |
+32,300
| New | +$395K |
|
315
McKesson
MCK
$96.5B
| $395K | 0.14% |
+2,400
| New | +$364K |
|
316
Pultegroup
PHM
$23.7B
| $395K | 0.14% |
+16,100
| New | +$376K |
|
317
JD.com
JD
$40.6B
| $392K | 0.14% |
10,000
-19,300
| -66% | -$728K |
|
318
Novartis
NVS
$297B
| $392K | 0.14% |
+5,245
| New | +$372K |
|
|
UMPQ
319
DELISTED
Umpqua Holdings Corp
UMPQ
| $391K | 0.14% |
+21,300
| New | +$378K |
|
|
CAVM
320
DELISTED
Cavium, Inc.
CAVM
| $391K | 0.14% |
+6,300
| New | +$440K |
|
321
STAG Industrial
STAG
$7.74B
| $389K | 0.13% |
+14,100
| New | +$377K |
|
|
CMA
322
DELISTED
Comerica
CMA
| $388K | 0.13% |
+5,300
| New | +$372K |
|
323
Prudential
PUK
$36.2B
| $386K | 0.13% |
+8,660
| New | +$374K |
|
324
Haemonetics
HAE
$3.52B
| $383K | 0.13% |
+9,700
| New | +$398K |
|
|
AIV
325
Aimco
AIV
$380M
| $382K | 0.13% |
66,811
+22,521
| +51% | +$131K |
|
Similar funds
MAM
NA
EHI
MW
BSG
RI
XI
TWA
Fox Run Management's Q2 2017 Portfolio in Review
As of Q2 2017, Fox Run Management held 950 positions worth $289M, up 18% from $245M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.
Fox Run Management deployed $42.9M of net new capital in Q2 2017, opening 406 new positions and adding to 107 existing holdings. Its largest new stake was Azenta: 65,500 shares worth $1.42M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $1.16M trimmed.
- Fox Run Management's largest Q2 2017 buy was Azenta: 65,500 shares worth $1.42M.
- Fox Run Management added most to ConocoPhillips in Q2 2017, an estimated $1.5M increase.
- Fox Run Management's biggest Q2 2017 reduction was Edwards Lifesciences, cutting an estimated $1.16M.
- Fox Run Management fully exited Oracle in Q2 2017, selling an estimated $1.39M.
- Fox Run Management's ten largest holdings make up 5.2% of its $289M portfolio in Q2 2017.
- Fox Run Management opened 406 new positions and closed 345 in Q2 2017.
- Fox Run Management's portfolio value rose 18% quarter-over-quarter to $289M.
Based on Fox Run Management's 13F filing for Q2 2017, filed 10 Jul 2017.